Medline ® Abstract for Reference 59
of 'Pulmonary atresia with intact ventricular septum (PA/IVS)'
59
TI
Midterm results for collaborative treatment of pulmonary atresia with intact ventricular septum.
AU
Hannan RL, Zabinsky JA, Stanfill RM, Ventura RA, Rossi AF, Nykanen DG, Zahn EM, Burke RP
SO
Ann Thorac Surg. 2009 Apr;87(4):1227-33.
BACKGROUND:
We report a single-institution experience using a collaborative surgical and catheter-based approach to the initial treatment of pulmonary atresia with intact ventricular septum.
METHODS:
A retrospective review was conducted of all neonates admitted with pulmonary atresia with intact ventricular septum from 1996 to March 2007.
RESULTS:
We identified 24 patients with a mean age at first intervention of 4.5 days with mean follow-up of 6.05 years (range, 1.9 to 12.7 years). Initial palliation was determined by right ventricular size, morphology, and presence or absence of right ventricular-dependent coronary circulation. Initial catheter-based pulmonary valve perforation and valvuloplasty was performed in 41.7% (10 of 24 patients; group A), and 58.3% (14 of 24 patients) had an initial systemic-to-pulmonary artery shunt (group B). Tricuspid valve size was significantly smaller in group B (median z-score, -0.52 group A versus -2.40 group B; p<0.001). Placement of a shunt after valvuloplasty in group A was required in 70.0%(7 of 10 patients). There was no mortality in group A, and 70.0% (7 of 10 patients) are in a two-ventricle pathway and 30.0% (3 of 10 patients) are in a 1.5-ventricle pathway. Group B had mortality of 14.3% (2 of 14 patients), both within 5 days of surgery. All group B patients remain in a single-ventricle pathway. Overall survival is 91.7% (22 of 24 patients).
CONCLUSIONS:
An individualized approach to this complex lesion has good results. If the right ventricle can be safely decompressed and appears usable, the need for a shunt after valvuloplasty does not preclude two-ventricle (or 1.5-ventricle) repair. Anatomy mandating a shunt as initial palliation has substantial early mortality.
AD
Department of Cardiovascular Surgery, Congenital Heart Institute at Miami Children's Hospital, Miami, Florida 33155, USA. rhannan001@aol.com
PMID
